Products, Technologies, Markets and Opportunities in Ophthalmology Surgical, Diagnostic, Device and Drug Markets Worldwide, Forecasts 2004 – 2012- Aarkstore Enterprise

This report details worldwide the incidence and prevalence by country/region of vision disorders (myopia, hyperopia, presbyopia, glaucoma, cataracts and retinal disease), and details the current and projected market for diagnostic and therapeutic products in the management of these vision disorders, including general vision diagnostics, diagnostics for glaucoma, corneal and retinal disorders, and therapeutic options for these disorders including use of pharmaceuticals, surgery and devices. The report details current products and technologies in use and the status of development of novel products under development. The report details the clinical and technology developments underlying this huge and evolving worldwide market, with data on products in development and on the market; market size and historic/forecast 2004-2012 (actual data for 2006/2007); competitor market shares; competitor profiles; and market opportunity. Separate size, growth and competitor share data are presented for the U.S., individual western European countries (UK, Germany, France, BeNeLux, Italy and Spain), Japan and other key international markets; Asia (India, Korea, Australia, Russia and China), the Americas (Canada, Mexico, Brazil) and Middle East and Africa categories. The report profiles 103 companies, with detailed product development, current positions and future outlook for major competitors, and brief profiles of smaller or more development stage companies with noteworthy novel or advanced research activities in the market.

The report establishes the market size for key international markets (as indicated above) for major technology segments as a baseline for and projecting growth in the market over a ten-year forecast. The report also assesses and projects the composition of the market (shifts in share based on technology) as technologies gain or lose relative market performance over this period.

For more information, kindly visit :
http://www.aarkstore.com/reports/Products-Technologies-Markets-and-Opportunities-in-Ophthalmology-Surgical-Diagnostic-Device-and-Drug-Markets-Worldwide-Forecasts-2004-2012-2058.html

Congestive Heart Failure Therapy Area Pipeline Report – Aarkstore Enterprise

Congestive Heart Failure Therapy Area Pipeline Report contains detailed information on the congestive heart failure drug pipeline. This report provides insight into the pipeline status of congestive heart failure drugs by company and by stage as well as a summary of the latest news and developments in this area.
 
 Scope of the report:
 
 Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and by stage, for each specific therapy area. The latest news, by company, also ensures that each report is fresh and up-to-date.
 
 In addition to new developments and disease specific pipeline projects, each report also contains extensive information in tabular format on a company’s full product pipeline and products by phase of development with regard to the therapy area.
 
 Full pipeline details, by stage, are provided and include detailed product descriptions, information on partnering activity plus clinical trial intelligence. Each Therapy Area Pipeline Report also provides detail on the top 20 companies with products in the early stage of development and the top 20 companies with products in the late stage of development. Finally, each report also provides a comparison with other major indications in the disease hub based on Marketed Products vs. Pipeline Products.
 
 Key benefits
 
 • Understand a company’s strategic position by accessing detailed independent intelligence on its product pipeline for specific therapy areas.
 • Keep track of your competitors and partners by better understanding their product pipeline.
 • Monitor a company’s research effectiveness by determining pipeline depth and number of products in development by clinical phase for specific disease areas.
 • Maintain a critical competitive advantage.

For more information, visit us at:
http://www.aarkstore.com/reports/Congestive-Heart-Failure-Therapy-Area-Pipeline-Report-14280.html

Melanoma or Skin Cancer Therapy Area Pipeline Report – Aarkstore Enterprise

Melanoma or Skin Cancer Therapy Area Pipeline Report contains detailed information on the melanoma or skin cancer drug pipeline. This report provides insight into the pipeline status of melanoma or skin cancer drugs by company and by stage as well as a summary of the latest news and developments in this area.
 
 Scope of the report:
 
 Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and by stage, for each specific therapy area. The latest news, by company, also ensures that each report is fresh and up-to-date.
 
 In addition to new developments and disease specific pipeline projects, each report also contains extensive information in tabular format on a company’s full product pipeline and products by phase of development with regard to the therapy area.
 
 Full pipeline details, by stage, are provided and include detailed product descriptions, information on partnering activity plus clinical trial intelligence. Each Therapy Area Pipeline Report also provides detail on the top 20 companies with products in the early stage of development and the top 20 companies with products in the late stage of development. Finally, each report also provides a comparison with other major indications in the disease hub based on Marketed Products vs. Pipeline Products.
 
 Key benefits
 
 • Understand a company’s strategic position by accessing detailed independent intelligence on its product pipeline for specific therapy areas.
 • Keep track of your competitors and partners by better understanding their product pipeline.
 • Monitor a company’s research effectiveness by determining pipeline depth and number of products in development by clinical phase for specific disease areas.
 • Maintain a critical competitive advantage.

For more information, kindly visit :
http://www.aarkstore.com/reports/Melanoma-or-Skin-Cancer-Therapy-Area-Pipeline-Report-14236.html

Lymphoma Therapy Area Pipeline Report – Aarkstore Enterprise

Lymphoma Therapy Area Pipeline Report contains detailed information on the lymphoma drug pipeline. This report provides insight into the pipeline status of lymphoma drugs by company and by stage as well as a summary of the latest news and developments in this area.
 
 Scope of the report:
 
 Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and by stage, for each specific therapy area. The latest news, by company, also ensures that each report is fresh and up-to-date.
 
 In addition to new developments and disease specific pipeline projects, each report also contains extensive information in tabular format on a company’s full product pipeline and products by phase of development with regard to the therapy area.
 
 Full pipeline details, by stage, are provided and include detailed product descriptions, information on partnering activity plus clinical trial intelligence. Each Therapy Area Pipeline Report also provides detail on the top 20 companies with products in the early stage of development and the top 20 companies with products in the late stage of development. Finally, each report also provides a comparison with other major indications in the disease hub based on Marketed Products vs. Pipeline Products.
 
 Key benefits
 
 • Understand a company’s strategic position by accessing detailed independent intelligence on its product pipeline for specific therapy areas.
 • Keep track of your competitors and partners by better understanding their product pipeline.
 • Monitor a company’s research effectiveness by determining pipeline depth and number of products in development by clinical phase for specific disease areas.
 • Maintain a critical competitive advantage.

For more information, visit us at:
http://www.aarkstore.com/reports/Lymphoma-Therapy-Area-Pipeline-Report-14234.html

Electrolyte Deficiencies Therapy Area Pipeline Report – Aarkstore Enterprise

Electrolyte Deficiencies Therapy Area Pipeline Report contains detailed information on the electrolyte deficiencies drug pipeline. This report provides insight into the pipeline status of electrolyte deficiencies drugs by company and by stage as well as a summary of the latest news and developments in this area.
 
 Scope of the report:
 
 Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and by stage, for each specific therapy area. The latest news, by company, also ensures that each report is fresh and up-to-date.
 
 In addition to new developments and disease specific pipeline projects, each report also contains extensive information in tabular format on a company’s full product pipeline and products by phase of development with regard to the therapy area.
 
 Full pipeline details, by stage, are provided and include detailed product descriptions, information on partnering activity plus clinical trial intelligence. Each Therapy Area Pipeline Report also provides detail on the top 20 companies with products in the early stage of development and the top 20 companies with products in the late stage of development. Finally, each report also provides a comparison with other major indications in the disease hub based on Marketed Products vs. Pipeline Products.
 
 Key benefits
 
 • Understand a company’s strategic position by accessing detailed independent intelligence on its product pipeline for specific therapy areas.
 • Keep track of your competitors and partners by better understanding their product pipeline.
 • Monitor a company’s research effectiveness by determining pipeline depth and number of products in development by clinical phase for specific disease areas.
 • Maintain a critical competitive advantage.

For more information, visit us at:
http://www.aarkstore.com/reports/Electrolyte-Deficiencies-Therapy-Area-Pipeline-Report-14202.html

Autoimmune Diseases Therapy Area Pipeline Report

Autoimmune Diseases Therapy Area Pipeline Report contains detailed information on the autoimmune diseases drug pipeline. This report provides insight into the pipeline status of autoimmune diseases drugs by company and by stage as well as a summary of the latest news and developments in this area.
 
 Scope of the report:
 
 Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and by stage, for each specific therapy area. The latest news, by company, also ensures that each report is fresh and up-to-date.
 
 In addition to new developments and disease specific pipeline projects, each report also contains extensive information in tabular format on a company’s full product pipeline and products by phase of development with regard to the therapy area.
 
 Full pipeline details, by stage, are provided and include detailed product descriptions, information on partnering activity plus clinical trial intelligence. Each Therapy Area Pipeline Report also provides detail on the top 20 companies with products in the early stage of development and the top 20 companies with products in the late stage of development. Finally, each report also provides a comparison with other major indications in the disease hub based on Marketed Products vs. Pipeline Products.
 
 Key benefits
 
 • Understand a company’s strategic position by accessing detailed independent intelligence on its product pipeline for specific therapy areas.
 • Keep track of your competitors and partners by better understanding their product pipeline.
 • Monitor a company’s research effectiveness by determining pipeline depth and number of products in development by clinical phase for specific disease areas.
 • Maintain a critical competitive advantage. 

For more information visit us at:
http://www.aarkstore.com/reports/Autoimmune-Diseases-Therapy-Area-Pipeline-Report-14184.html